Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. TuralOnur S, Sokucu SN, Dalar L, Iliaz S, Kara K, Buyukkale S et al (2016) Are neutrophil/ lymphocyte ratio and platelet/lymphocyte ratio reliable parameters as prognostic indicators in malignant mesothelioma? Ther Clin Risk Manag 12:651–656
2. Sugarbaker DJ, Wolf AS, Chirieac LR, Godleski JJ, Tilleman TR, Jaklitsch MT et al (2011) Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy. Eur J Cardiothorac Surg 40:298–303
3. Treasure T, Lang-Lazdunski L, Waller D, Bliss JM, Tan C, Entwisle J et al (2011) Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol 12:763–772
4. Rusch V, Baldini EH, Bueno R et al (2013) The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: meeting summary of the International Mesothelioma Interest Group Congress, September 11–14, 2012, Boston. Mass J Thorac Cardiovasc Surg 145:909–910
5. Rice D, Rusch V, Pass H, Asamura H, Nakano T, Edwards J et al (2011) Recommendations for uniform definitions of surgical techniques for malignant pleural mesothelioma: a consensus report of the international association for the study of lung cancer international staging committee and the international mesothelioma interest group. J Thorac Oncol 6(8):1304–1312. https://doi.org/10.1097/JTO.0b013e3182208e3f
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献